The 9xchange platform releases drugs from owners who are unlikely to pursue them further, while providing access to the right AI/ML technologies to unleash new value BOSTON, Nov. 6, 2023 /PRNewswire/ — PhaseV, a pioneer in causal machine learning (ML) for dynamic clinical trial analysis…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.